[ORGANIZATION]
Vertex Pharmaceuticals
Featured in 9 tracked stories · first seen
Situations
Gene-editing technology clinical progress and risks
5 clusters · 13 sources · last updated
Latest: Origin Genomics founder advocates for human embryo gene editing
Advancements in gene-editing technologies, including CRISPR-Cas9, base editing, and prime editing, are demonstrating significant therapeutic potential. Research from the Broad Institute indicates these tools are being ut
AI sector market activity and growth
2 clusters · 7 sources · last updated
Latest: Artificial intelligence stocks see continued market interest
The artificial intelligence sector is driving significant market activity and investor interest across multiple industries. In the biotechnology space, companies like Vertex Pharmaceuticals are reporting strong revenue
Also covered in
-
North Macedonia expands cystic fibrosis therapy to 126 patients
[HEALTH] · 2 sources ·
-
Swiss Federal Council outlines two-stage plan for rare disease care
[HEALTH] · 2 sources ·
-
Biotech sector updates: Lineage Cell and Latigo Biotherapeutics
[BUSINESS] · 2 sources ·
-
Sionna Therapeutics and Vectus Biosystems target orphan lung disease markets
[BUSINESS] · 2 sources ·